DEUTSCHE BETEILIGUNGS AG (DBAN.DE) Stock Fundamental Analysis
Europe - Frankfurt Stock Exchange - FRA:DBAN - DE000A1TNUT7 - Common Stock
25.6 EUR
-0.3 (-1.16%)
DBAN gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 125 industry peers in the Capital Markets industry. While DBAN is still in line with the averages on profitability rating, there are concerns on its financial health. DBAN is valued expensive and it does not seem to be growing.
1. Profitability
1.1 Basic Checks
- In the past year DBAN was profitable.
- In the past year DBAN had a positive cash flow from operations.
- In multiple years DBAN reported negative net income over the last 5 years.
- In multiple years DBAN reported negative operating cash flow during the last 5 years.
1.2 Ratios
- With a decent Return On Assets value of 3.38%, DBAN is doing good in the industry, outperforming 65.60% of the companies in the same industry.
- DBAN's Return On Equity of 4.81% is in line compared to the rest of the industry. DBAN outperforms 44.80% of its industry peers.
- With a Return On Invested Capital value of 2.53%, DBAN perfoms like the industry average, outperforming 59.20% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.38% | ||
| ROE | 4.81% | ||
| ROIC | 2.53% |
ROA(3y)1.68%
ROA(5y)5.34%
ROE(3y)1.96%
ROE(5y)5.68%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- DBAN has a Profit Margin of 31.10%. This is in the better half of the industry: DBAN outperforms 78.40% of its industry peers.
- In the last couple of years the Profit Margin of DBAN has declined.
- DBAN's Operating Margin of 32.22% is fine compared to the rest of the industry. DBAN outperforms 71.20% of its industry peers.
- In the last couple of years the Operating Margin of DBAN has declined.
- DBAN's Gross Margin of 89.98% is amongst the best of the industry. DBAN outperforms 90.40% of its industry peers.
- In the last couple of years the Gross Margin of DBAN has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 32.22% | ||
| PM (TTM) | 31.1% | ||
| GM | 89.98% |
OM growth 3Y-18.51%
OM growth 5Y-4.58%
PM growth 3Y-19.55%
PM growth 5Y-6.09%
GM growth 3Y-1.43%
GM growth 5Y-0.83%
2. Health
2.1 Basic Checks
- Compared to 1 year ago, DBAN has less shares outstanding
- Compared to 5 years ago, DBAN has more shares outstanding
- The debt/assets ratio for DBAN is higher compared to a year ago.
2.2 Solvency
- DBAN has an Altman-Z score of 1.82. This is not the best score and indicates that DBAN is in the grey zone with still only limited risk for bankruptcy at the moment.
- DBAN has a Altman-Z score of 1.82. This is in the better half of the industry: DBAN outperforms 68.80% of its industry peers.
- DBAN has a debt to FCF ratio of 93.97. This is a negative value and a sign of low solvency as DBAN would need 93.97 years to pay back of all of its debts.
- With a Debt to FCF ratio value of 93.97, DBAN perfoms like the industry average, outperforming 56.80% of the companies in the same industry.
- A Debt/Equity ratio of 0.31 indicates that DBAN is not too dependend on debt financing.
- Looking at the Debt to Equity ratio, with a value of 0.31, DBAN is in the better half of the industry, outperforming 68.80% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.31 | ||
| Debt/FCF | 93.97 | ||
| Altman-Z | 1.82 |
ROIC/WACCN/A
WACCN/A
2.3 Liquidity
- DBAN has a Current Ratio of 0.84. This is a bad value and indicates that DBAN is not financially healthy enough and could expect problems in meeting its short term obligations.
- Looking at the Current ratio, with a value of 0.84, DBAN is in line with its industry, outperforming 52.80% of the companies in the same industry.
- A Quick Ratio of 0.84 indicates that DBAN may have some problems paying its short term obligations.
- With a Quick ratio value of 0.84, DBAN perfoms like the industry average, outperforming 53.60% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.84 | ||
| Quick Ratio | 0.84 |
3. Growth
3.1 Past
- The earnings per share for DBAN have decreased strongly by -39.70% in the last year.
- Measured over the past years, DBAN shows a decrease in Earnings Per Share. The EPS has been decreasing by -3.13% on average per year.
- Looking at the last year, DBAN shows a very negative growth in Revenue. The Revenue has decreased by -10.87% in the last year.
- DBAN shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 7.25% yearly.
EPS 1Y (TTM)-39.7%
EPS 3Y-38.96%
EPS 5Y-3.13%
EPS Q2Q%-99.1%
Revenue 1Y (TTM)-10.87%
Revenue growth 3Y-21%
Revenue growth 5Y7.25%
Sales Q2Q%-61.51%
3.2 Future
- Based on estimates for the next years, DBAN will show a very negative growth in Earnings Per Share. The EPS will decrease by -15.12% on average per year.
- The Revenue is expected to decrease by -7.69% on average over the next years.
EPS Next Y-71.64%
EPS Next 2Y-35.68%
EPS Next 3Y-15.12%
EPS Next 5YN/A
Revenue Next Year-22.08%
Revenue Next 2Y-6.46%
Revenue Next 3Y-7.69%
Revenue Next 5YN/A
3.3 Evolution
- The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
- When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
- DBAN is valuated rather expensively with a Price/Earnings ratio of 17.53.
- Based on the Price/Earnings ratio, DBAN is valued a bit cheaper than 68.00% of the companies in the same industry.
- DBAN is valuated rather cheaply when we compare the Price/Earnings ratio to 27.30, which is the current average of the S&P500 Index.
- With a Price/Forward Earnings ratio of 12.50, DBAN is valued correctly.
- Compared to the rest of the industry, the Price/Forward Earnings ratio of DBAN indicates a rather cheap valuation: DBAN is cheaper than 83.20% of the companies listed in the same industry.
- The average S&P500 Price/Forward Earnings ratio is at 24.04. DBAN is valued slightly cheaper when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 17.53 | ||
| Fwd PE | 12.5 |
4.2 Price Multiples
- Compared to the rest of the industry, the Price/Free Cash Flow ratio of DBAN is on the same level as its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 234.08 | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
- A cheap valuation may be justified as DBAN's earnings are expected to decrease with -15.12% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-35.68%
EPS Next 3Y-15.12%
5. Dividend
5.1 Amount
- With a Yearly Dividend Yield of 3.91%, DBAN has a reasonable but not impressive dividend return.
- DBAN's Dividend Yield is a higher than the industry average which is at 3.32.
- DBAN's Dividend Yield is rather good when compared to the S&P500 average which is at 1.92.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.91% |
5.2 History
- The dividend of DBAN decreases each year by -5.78%.
Dividend Growth(5Y)-5.78%
Div Incr Years1
Div Non Decr Years2
5.3 Sustainability
- 73.85% of the earnings are spent on dividend by DBAN. This is not a sustainable payout ratio.
- DBAN's earnings and Dividend Rate are declining. This means the current dividend is most likely not sustainable.
DP73.85%
EPS Next 2Y-35.68%
EPS Next 3Y-15.12%
FRA:DBAN (1/14/2026, 5:28:58 PM)
25.6
-0.3 (-1.16%)
Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)11-06 2025-11-06
Earnings (Next)03-10 2026-03-10/amc
Inst Owners11.66%
Inst Owner ChangeN/A
Ins Owners38.61%
Ins Owner ChangeN/A
Market Cap481.28M
Revenue(TTM)96.86M
Net Income(TTM)30.13M
Analysts89.23
Price Target38.53 (50.51%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.91% |
Yearly Dividend1.01
Dividend Growth(5Y)-5.78%
DP73.85%
Div Incr Years1
Div Non Decr Years2
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-2.57%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-6.46%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 17.53 | ||
| Fwd PE | 12.5 | ||
| P/S | 4.97 | ||
| P/FCF | 234.08 | ||
| P/OCF | 181.96 | ||
| P/B | 0.77 | ||
| P/tB | 0.83 | ||
| EV/EBITDA | N/A |
EPS(TTM)1.46
EY5.7%
EPS(NY)2.05
Fwd EY8%
FCF(TTM)0.11
FCFY0.43%
OCF(TTM)0.14
OCFY0.55%
SpS5.15
BVpS33.3
TBVpS30.72
PEG (NY)N/A
PEG (5Y)N/A
Graham Number33.08
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.38% | ||
| ROE | 4.81% | ||
| ROCE | 3.86% | ||
| ROIC | 2.53% | ||
| ROICexc | 2.68% | ||
| ROICexgc | 2.85% | ||
| OM | 32.22% | ||
| PM (TTM) | 31.1% | ||
| GM | 89.98% | ||
| FCFM | 2.12% |
ROA(3y)1.68%
ROA(5y)5.34%
ROE(3y)1.96%
ROE(5y)5.68%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3Y-35.11%
ROICexgc growth 5Y-7.26%
ROICexc growth 3Y-36.76%
ROICexc growth 5Y-8.68%
OM growth 3Y-18.51%
OM growth 5Y-4.58%
PM growth 3Y-19.55%
PM growth 5Y-6.09%
GM growth 3Y-1.43%
GM growth 5Y-0.83%
F-Score4
Asset Turnover0.11
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.31 | ||
| Debt/FCF | 93.97 | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | N/A | ||
| Cap/Sales | 0.61% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | N/A | ||
| Profit Quality | 6.82% | ||
| Current Ratio | 0.84 | ||
| Quick Ratio | 0.84 | ||
| Altman-Z | 1.82 |
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)0.91%
Cap/Sales(5y)1.33%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-39.7%
EPS 3Y-38.96%
EPS 5Y-3.13%
EPS Q2Q%-99.1%
EPS Next Y-71.64%
EPS Next 2Y-35.68%
EPS Next 3Y-15.12%
EPS Next 5YN/A
Revenue 1Y (TTM)-10.87%
Revenue growth 3Y-21%
Revenue growth 5Y7.25%
Sales Q2Q%-61.51%
Revenue Next Year-22.08%
Revenue Next 2Y-6.46%
Revenue Next 3Y-7.69%
Revenue Next 5YN/A
EBIT growth 1Y-37.36%
EBIT growth 3Y-35.63%
EBIT growth 5Y2.34%
EBIT Next Year-64.73%
EBIT Next 3Y-7.7%
EBIT Next 5YN/A
FCF growth 1Y109.22%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y112.05%
OCF growth 3YN/A
OCF growth 5YN/A
DEUTSCHE BETEILIGUNGS AG / DBAN.DE FAQ
What is the ChartMill fundamental rating of DEUTSCHE BETEILIGUNGS AG (DBAN.DE) stock?
ChartMill assigns a fundamental rating of 3 / 10 to DBAN.DE.
What is the valuation status of DEUTSCHE BETEILIGUNGS AG (DBAN.DE) stock?
ChartMill assigns a valuation rating of 3 / 10 to DEUTSCHE BETEILIGUNGS AG (DBAN.DE). This can be considered as Overvalued.
What is the profitability of DBAN stock?
DEUTSCHE BETEILIGUNGS AG (DBAN.DE) has a profitability rating of 4 / 10.
What is the financial health of DEUTSCHE BETEILIGUNGS AG (DBAN.DE) stock?
The financial health rating of DEUTSCHE BETEILIGUNGS AG (DBAN.DE) is 3 / 10.
What is the earnings growth outlook for DEUTSCHE BETEILIGUNGS AG?
The Earnings per Share (EPS) of DEUTSCHE BETEILIGUNGS AG (DBAN.DE) is expected to decline by -71.64% in the next year.